Cardinal Health tucks in Harvard Drug Group for $1.115 billion
Acquisition increases scale of generics distribution
Having just swallowed Cordis, a J&J subsidiary for which it finalized acquisition in May, Cardinal Health enters June with the purchase of The Harvard Drug Group (THDG), a $450-million/yr drug distributor based in Livonia, MI. THDG is owned by Court Square Capital Partners, a private equity firm; the acquisition is expected to close in early 2016.
